214 related articles for article (PubMed ID: 25645889)
1. Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.
Nagoshi N; Fehlings MG
Expert Opin Investig Drugs; 2015 May; 24(5):645-58. PubMed ID: 25645889
[TBL] [Abstract][Full Text] [Related]
2. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
Tator CH; Hashimoto R; Raich A; Norvell D; Fehlings MG; Harrop JS; Guest J; Aarabi B; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):157-229. PubMed ID: 22985382
[TBL] [Abstract][Full Text] [Related]
3. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.
Hawryluk GW; Rowland J; Kwon BK; Fehlings MG
Neurosurg Focus; 2008; 25(5):E14. PubMed ID: 18980474
[TBL] [Abstract][Full Text] [Related]
4. Emerging repair, regeneration, and translational research advances for spinal cord injury.
Kwon BK; Sekhon LH; Fehlings MG
Spine (Phila Pa 1976); 2010 Oct; 35(21 Suppl):S263-70. PubMed ID: 20881470
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial.
Fehlings MG; Wilson JR; Frankowski RF; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Harkema SJ; Guest JD; Tator CH; Burau KD; Johnson MW; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):151-6. PubMed ID: 22985381
[TBL] [Abstract][Full Text] [Related]
6. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.
Jackson VM; Price DA; Carpino PA
Expert Opin Investig Drugs; 2014 Aug; 23(8):1055-66. PubMed ID: 25000213
[TBL] [Abstract][Full Text] [Related]
7. Fampridine Acorda Therapeutics.
Darlington C
Curr Opin Investig Drugs; 2000 Nov; 1(3):375-9. PubMed ID: 11249722
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury.
Baptiste DC; Tighe A; Fehlings MG
Expert Opin Investig Drugs; 2009 May; 18(5):663-73. PubMed ID: 19379122
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
[TBL] [Abstract][Full Text] [Related]
10. Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat.
Sonmez E; Kabatas S; Ozen O; Karabay G; Turkoglu S; Ogus E; Yilmaz C; Caner H; Altinors N
Spine (Phila Pa 1976); 2013 Jul; 38(15):1253-9. PubMed ID: 23370685
[TBL] [Abstract][Full Text] [Related]
11. North American Clinical Trials Network for the Treatment of Spinal Cord Injury: goals and progress.
Grossman RG; Toups EG; Frankowski RF; Burau KD; Howley S
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):6-10. PubMed ID: 22985365
[TBL] [Abstract][Full Text] [Related]
12. Designing drugs that encourage spinal cord injury healing.
Festoff BW
Expert Opin Drug Discov; 2014 Oct; 9(10):1151-65. PubMed ID: 25063571
[TBL] [Abstract][Full Text] [Related]
13. Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development.
O'Brien TJ; Ben-Menachem E; Bertram EH; Collins SD; Kokaia M; Lerche H; Klitgaard H; Staley KJ; Vaudano E; Walker MC; Simonato M
Epilepsia; 2013 Aug; 54 Suppl 4():70-4. PubMed ID: 23909855
[TBL] [Abstract][Full Text] [Related]
14. Opinions on the preclinical evaluation of novel therapies for spinal cord injury: a comparison between researchers and spinal cord-injured individuals.
Kwon BK; Ghag A; Reichl L; Dvorak MF; Illes J; Tetzlaff W
J Neurotrauma; 2012 Sep; 29(14):2367-74. PubMed ID: 22776047
[TBL] [Abstract][Full Text] [Related]
15. Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.
Valentin N; Acosta A; Camilleri M
Expert Opin Investig Drugs; 2015 Jun; 24(6):769-79. PubMed ID: 25971881
[TBL] [Abstract][Full Text] [Related]
16. Translational research in spinal cord injury: a survey of opinion from the SCI community.
Kwon BK; Hillyer J; Tetzlaff W
J Neurotrauma; 2010 Jan; 27(1):21-33. PubMed ID: 19751098
[TBL] [Abstract][Full Text] [Related]
17. Epothilone D (Kosan/Roche).
Kolman A
Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord.
Greene KA; Marciano FF; Sonntag VK
J Spinal Disord; 1996 Oct; 9(5):355-66. PubMed ID: 8938603
[TBL] [Abstract][Full Text] [Related]
19. Phase II drugs under clinical investigation for the treatment of chronic constipation.
Mozaffari S; Didari T; Nikfar S; Abdollahi M
Expert Opin Investig Drugs; 2014 Nov; 23(11):1485-97. PubMed ID: 24960333
[TBL] [Abstract][Full Text] [Related]
20. Limiting spinal cord injury by pharmacological intervention.
Priestley JV; Michael-Titus AT; Tetzlaff W
Handb Clin Neurol; 2012; 109():463-84. PubMed ID: 23098731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
